Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the un-audited Standalone and Consolidate Financial Results of the Company for the quarter and half year ended September 30, 2026 and the proposal for raising of funds by way of rights issue of equity shares.

October 29, 2026 To, To, BSE Limited, The Manager, 25, P. J. Towers, Listing Department, Dalal Street, National Stock Exchange of India Ltd., Mumbai – 400 001 Exchange Plaza, Bandra Kurla Complex, Ref: Company Scrip Code: 532834 Bandra (East), Mumbai- 400051 Ref: Symbol: CAMLINFINE || Series: EQ Sub: Intimation about the Board Meeting of Camlin Fine Sciences Limited (the “Company”) to be held on November 3, 2026. Dear Sir/Madam, Pursuant to Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2026, inter alia to consider and approve the following: 1. Un-audited Standalone and Consolidate Financial Results of the Company for the quarter and half year ended September 30, 2026. 2. The proposal for raising of funds by way of rights issue of equity shares under applicable laws or issue of any other securities of the Company, subject to regulatory/ statutory and other approvals, as may be required. Further, the Company has vide its letter dated September 24, 2026 intimated regarding the closure of the Trading Window for trading in the Company’s equity shares from October 1, 2026 till November 5, 2026 for Designated Persons and their immediate relatives. We request you to take the above on record and disseminate the same on your website. Thanking you, Yours faithfully, For Camlin Fine Sciences Limited Rahul Sawale Company Secretary & V. P. Legal